BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 26260454)

  • 1. MicroRNA-200c and microRNA-31 regulate proliferation, colony formation, migration and invasion in serous ovarian cancer.
    Ibrahim FF; Jamal R; Syafruddin SE; Ab Mutalib NS; Saidin S; MdZin RR; Hossain Mollah MM; Mokhtar NM
    J Ovarian Res; 2015 Aug; 8():56. PubMed ID: 26260454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer.
    Kan CW; Hahn MA; Gard GB; Maidens J; Huh JY; Marsh DJ; Howell VM
    BMC Cancer; 2012 Dec; 12():627. PubMed ID: 23272653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-6 regulates epithelial ovarian cancer EMT, invasion, and metastasis by modulating Let-7c and miR-200c through the STAT3/HIF-1α pathway.
    Guo QY; Song JN; Chen YM; Yuan HN; Xue WS; Sun Y; Niu XL; Wang Y; Chen X
    Med Oncol; 2024 May; 41(6):155. PubMed ID: 38744773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA-200c modulates the epithelial-to-mesenchymal transition in human renal cell carcinoma metastasis.
    Wang X; Chen X; Wang R; Xiao P; Xu Z; Chen L; Hang W; Ruan A; Yang H; Zhang X
    Oncol Rep; 2013 Aug; 30(2):643-50. PubMed ID: 23754305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.
    Hur K; Toiyama Y; Takahashi M; Balaguer F; Nagasaka T; Koike J; Hemmi H; Koi M; Boland CR; Goel A
    Gut; 2013 Sep; 62(9):1315-26. PubMed ID: 22735571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiRNA-802 suppresses proliferation and migration of epithelial ovarian cancer cells by targeting YWHAZ.
    Yang B; Sun L; Liang L
    J Ovarian Res; 2019 Oct; 12(1):100. PubMed ID: 31640760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-101 inhibits growth of epithelial ovarian cancer by relieving chromatin-mediated transcriptional repression of p21(waf¹/cip¹).
    Semaan A; Qazi AM; Seward S; Chamala S; Bryant CS; Kumar S; Morris R; Steffes CP; Bouwman DL; Munkarah AR; Weaver DW; Gruber SA; Batchu RB
    Pharm Res; 2011 Dec; 28(12):3079-90. PubMed ID: 21818714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections.
    Marchini S; Cavalieri D; Fruscio R; Calura E; Garavaglia D; Fuso Nerini I; Mangioni C; Cattoretti G; Clivio L; Beltrame L; Katsaros D; Scarampi L; Menato G; Perego P; Chiorino G; Buda A; Romualdi C; D'Incalci M
    Lancet Oncol; 2011 Mar; 12(3):273-85. PubMed ID: 21345725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microarray expression identification of differentially expressed genes in serous epithelial ovarian cancer compared with bulk normal ovarian tissue and ovarian surface scrapings.
    Grisaru D; Hauspy J; Prasad M; Albert M; Murphy KJ; Covens A; Macgregor PF; Rosen B
    Oncol Rep; 2007 Dec; 18(6):1347-56. PubMed ID: 17982616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of miR-141 and miR-200a Increase
    Wahab NA; Othman Z; Nasri NWM; Mokhtar MH; Ibrahim SF; Hamid AA; Raja Ali RA; Mokhtar NM
    Int J Environ Res Public Health; 2020 Apr; 17(8):. PubMed ID: 32316405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An inhibitory effect of miR-22 on cell migration and invasion in ovarian cancer.
    Li J; Liang S; Yu H; Zhang J; Ma D; Lu X
    Gynecol Oncol; 2010 Dec; 119(3):543-8. PubMed ID: 20869762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-200c regulates invasion, proliferation and EMT of anaplastic thyroid cancer cells by targeting parathyroid hormone like hormone.
    Zhang Y; Duan Y; Wu C; Peng W; Chen W; Wang L; Deng Z
    Growth Factors; 2022 Nov; 40(5-6):175-185. PubMed ID: 36067091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
    Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
    Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MicroRNA-16 regulates the proliferation, invasion and apoptosis of ovarian epithelial carcinoma cells in vitro].
    Tang R; Cui ZM; Lou YH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):846-50. PubMed ID: 23302126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic Role of miR-200c-3p in High-Grade Serous Ovarian Cancer Progression via Targeting the 3'-Untranslated Region of DLC1.
    Ankasha SJ; Shafiee MN; Abdul Wahab N; Raja Ali RA; Mokhtar NM
    Int J Environ Res Public Health; 2021 May; 18(11):. PubMed ID: 34071861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of a TMPO-AS1/microRNA-200c/TMEFF2 ceRNA network in the malignant behaviors and 5-FU resistance of ovarian cancer cells.
    Li H; Zhou Y; Cheng H; Tian J; Yang S
    Exp Mol Pathol; 2020 Aug; 115():104481. PubMed ID: 32497621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-744-5p inhibits cellular proliferation and invasion via targeting ARF1 in epithelial ovarian cancer.
    Zhao LG; Wang J; Li J; Li QF
    Kaohsiung J Med Sci; 2020 Oct; 36(10):799-807. PubMed ID: 32558345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-34a and miR-200c Have an Additive Tumor-Suppressive Effect on Breast Cancer Cells and Patient Prognosis.
    Mansoori B; Silvestris N; Mohammadi A; Khaze V; Baghbani E; Mokhtarzadeh A; Shanehbandi D; Derakhshani A; Duijf PHG; Baradaran B
    Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33673143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation.
    Zhou X; Zhao F; Wang ZN; Song YX; Chang H; Chiang Y; Xu HM
    Oncol Rep; 2012 Feb; 27(2):447-54. PubMed ID: 21971665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA‑320 targets mitogen‑activated protein kinase 1 to inhibit cell proliferation and invasion in epithelial ovarian cancer.
    Xu Y; Hu J; Zhang C; Liu Y
    Mol Med Rep; 2017 Dec; 16(6):8530-8536. PubMed ID: 28990044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.